Cawachi Limited
Notice Regarding Resolution on Share Buyback
Maximum of 700,000 shares to be acquired, up to 3.13% of issued shares, total amount up to 2,000,000,000 yen, during the period from 2026/08/12 to 2026/09/07.
Key Figures
- Type of shares to be acquired: Our common stock
- Total number of shares that can be acquired: 700,000 shares (3.13%)
- Total acquisition value: 2,000,000,000 yen
- Acquisition period: 2026 August 12 – 2026 September 7
AI要約
Purpose and overview of the share buyback
The company has decided to acquire treasury stock to enhance shareholder value, strengthen shareholder returns, and execute a flexible capital policy. The target is our ordinary shares, with an upper limit of 3.13% of issued shares and a total amount cap of 2,000,000,000 yen. The acquisition period is from August 12, 2026 to September 7, 2026.
Background and impact
The treasury stock acquisition is positioned to improve financial policy flexibility and offset dilution as part of the shareholder return policy. At this time, any other financial indicators or direct impact on performance are not known from this disclosure.
Kawachi Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
